EX-99.1 2 prlb-2025502xexx991.htm EX-99.1 Document

Exhibit 99.1
logoa.jpg
logo1a.jpg
Protolabs Reports Financial Results for the First Quarter of 2025
Total Revenue of $126.2 Million
GAAP Earnings Per Share of $0.15, Non-GAAP Earnings Per Share of $0.33
MINNEAPOLIS – May 2, 2025 – Proto Labs, Inc. ("Protolabs" or the "Company") (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the first quarter ended March 31, 2025.
First Quarter 2025 Financial Highlights:
•Revenue was $126.2 million, a 1.3% decrease compared to revenue of $127.9 million in the first quarter of 2024.
•Revenue fulfilled through the Protolabs Network was $26.3 million, a 10.0% increase compared to the first quarter of 2024.
•Net income was $3.6 million, or $0.15 per diluted share, compared to $5.3 million, or $0.20 per diluted share, in the first quarter of 2024.
•Non-GAAP net income was $8.1 million, or $0.33 per diluted share, compared to $10.4 million, or $0.40 per diluted share, in the first quarter of 2024. See “Non-GAAP Financial Measures” below.

“Protolabs started the year strong, with revenue and earnings per share near the top of our guidance range and increases in both the number of customers utilizing our combined factory and network offer and spend per customer,” said Rob Bodor, President and Chief Executive Officer. “Our first quarter performance establishes a solid foundation for growth in 2025. We are continuing to evolve Protolabs beyond prototyping and into production by enhancing our manufacturing capabilities, unlocking value from our reorganized internal operating structure, and serving our customers more efficiently across the product lifecycle.”

"As the tariff landscape evolves, we believe we are well positioned to continue serving our customers through our geographically diverse factory and network fulfillment model," continued Bodor. "Protolabs has a proven track record of adapting faster than anyone to support our customers in times of supply chain disruption, and we are prepared to capitalize on emerging opportunities as the global landscape continues to shift."

Dan Schumacher, Chief Financial Officer, commented: “Our industry-leading profitability and cash flow generation, combined with zero debt on our balance sheet, strongly position us to invest in growth and navigate periods of uncertainty. We continued to return capital to shareholders during the quarter by repurchasing $20.9 million of common stock.”

Additional First Quarter 2025 Highlights:
•Customer contact information
◦Protolabs served 21,627 customer contacts during the quarter.
◦Revenue per customer contact increased 2.5% year-over-year to $5,836.
•EBITDA was $13.6 million. See “Non-GAAP Financial Measures” below.
•Adjusted EBITDA was $17.4 million, or 13.8% of revenue, compared to $20.2 million, or 15.8% of revenue, in 2024. See “Non-GAAP Financial Measures” below.
•Cash and investments balance was $116.3 million as of March 31, 2025.

Second Quarter 2025 Outlook

In the second quarter of 2025, the Company expects to generate revenue between $124.0 million and $132.0 million.



The Company expects second quarter 2025 diluted net income per share between $0.11 and $0.19, and non-GAAP diluted net income per share between $0.30 and $0.38. See "Non-GAAP Financial Measures" below.
Non-GAAP Financial Measures
The Company has included non-GAAP revenue growth by region and by service line that excludes the impact of changes in foreign currency exchange rates (collectively, “non-GAAP revenue growth”). Management believes these metrics, when viewed in conjunction with the comparable GAAP metrics, are useful in evaluating the underlying business trends and ongoing operating performance of the Company.
The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency and benefits related to exit and disposal activities (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized (gain) loss on foreign currency and benefits related to exit and disposal activities (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense, in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense and benefits related to exit and disposal activities (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP net income and non-GAAP net income per share, in each case, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and benefits related to exit and disposal activities (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP net income per share, non-GAAP gross margin, non-GAAP operating margin, non-GAAP revenue growth by region and by service line, and Adjusted EBITDA and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends, provide useful measures for period-to-period comparisons of the Company’s business, and in determining executive and senior management incentive compensation. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. These non-GAAP financial measures exclude significant expenses and income that are required by GAAP to be recorded in our condensed consolidated financial statements and are subject to inherent limitations. Investors should review the reconciliations of non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.
Conference Call
The Company has scheduled a conference call to discuss its first quarter 2025 financial results and second quarter 2025 outlook today, May 2, 2025 at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/ngihgh3z/. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.
About Protolabs
Protolabs is the fastest and most comprehensive manufacturing service from prototyping to production. Our digital factories produce low-volume parts in days while Protolabs Network unlocks advanced capabilities and volume pricing


through its highly vetted manufacturing partners. The result? One digital manufacturing source for product developers, engineers, and supply chain teams across the globe. See what's next at protolabs.com.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Source: Proto Labs, Inc.

Investor Relations Contacts:
Protolabs
Ryan Johnsrud, 612-225-4873
Manager – Investor Relations and FP&A
ryan.johnsrud@protolabs.com

Gateway Group, Inc.
949-574-3860
PRLB@gateway-grp.com
Media Contact:
Protolabs
Brent Renneke, 763-479-7704
Marketing Communications Manager
brent.renneke@protolabs.com


Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
March 31,
2025		December 31,
2024
(Unaudited)
Assets
Current assets
Cash and cash equivalents$82,692 $89,071 
Short-term marketable securities14,154 14,019 
Accounts receivable, net73,904 66,504 
Inventory13,202 12,305 
Income taxes receivable864 2,906 
Prepaid expenses and other current assets9,594 10,049 
Total current assets194,410 194,854 
Property and equipment, net221,207 227,263 
Goodwill273,991 273,991 
Other intangible assets, net20,775 21,422 
Long-term marketable securities19,425 17,773 
Operating lease assets2,461 2,993 
Finance lease assets625 692 
Other long-term assets4,556 4,524 
Total assets$737,450 $743,512 
Liabilities and shareholders' equity  
Current liabilities  
Accounts payable$16,288 $15,504 
Accrued compensation18,554 16,550 
Accrued liabilities and other24,172 19,621 
Current operating lease liabilities1,132 1,287 
Current finance lease liabilities312 309 
Income taxes payable1,634 — 
Total current liabilities62,092 53,271 
Long-term operating lease liabilities1,491 1,633 
Long-term finance lease liabilities207 287 
Long-term deferred tax liabilities12,062 13,565 
Other long-term liabilities4,797 4,605 
Shareholders' equity656,801 670,151 
Total liabilities and shareholders' equity$737,450 $743,512 


Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
March 31,
20252024
Revenue
Injection Molding$48,723 $52,663 
CNC Machining52,843 49,932 
3D Printing20,194 21,582 
Sheet Metal4,211 3,553 
Other Revenue234 160 
Total Revenue126,205 127,890 
Cost of revenue70,507 70,423 
Gross profit55,698 57,467 
Operating expenses
Marketing and sales23,749 23,160 
Research and development10,609 11,167 
General and administrative16,848 16,313 
Benefits related to exit and disposal activities(39)— 
Total operating expenses51,167 50,640 
Income from operations4,531 6,827 
Other income, net1,454 899 
Income before income taxes5,985 7,726 
Provision for income taxes2,386 2,458 
Net income$3,599 $5,268 
Net income per share:
Basic$0.15 $0.21 
Diluted$0.15 $0.20 
Shares used to compute net income per share:
Basic24,135,32025,624,949
Diluted24,435,844 25,784,987


Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Three Months Ended
March 31,
20252024
Operating activities
Net income$3,599 $5,268 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization8,694 9,103 
Stock-based compensation expense3,992 4,276 
Deferred taxes(1,552)(2,247)
Interest on finance lease obligations6 10 
Impairments related to exit and closure of facilities219 — 
Gain on disposal of property and equipment— (22)
Other43 63 
Changes in operating assets and liabilities3,378 4,887 
Net cash provided by operating activities18,379 21,338 
Investing activities
Purchases of property, equipment and other capital assets(1,262)(2,587)
Proceeds from sales of property, equipment and other capital assets— 22 
Purchases of marketable securities(6,552)— 
Proceeds from call redemptions and maturities of marketable securities4,905 6,984 
Net cash (used in) provided by investing activities(2,909)4,419 
Financing activities
Proceeds from issuance of common stock from equity plans287 — 
Purchases of shares withheld for tax obligations(1,248)(533)
Repurchases of common stock(20,890)(16,013)
Principal repayments of finance lease obligations(76)(73)
Net cash used in financing activities(21,927)(16,619)
Effect of exchange rate changes on cash and cash equivalents78 (124)
Net (decrease) increase in cash and cash equivalents(6,379)9,014 
Cash and cash equivalents, beginning of period89,071 83,790 
Cash and cash equivalents, end of period$82,692 $92,804 


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income and Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
March 31,
20252024
Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and benefits related to exit and disposal activities
GAAP net income$3,599 $5,268 
Add back:
Stock-based compensation expense3,992 4,276 
Amortization expense908 987 
Unrealized (gain) loss on foreign currency(135)237 
Benefit related to exit and disposal activities(39)— 
Total adjustments 1
4,726 5,500 
Income tax benefits on adjustments 2
(242)(354)
Non-GAAP net income$8,083 $10,414 
Non-GAAP net income per share:
Basic$0.33 $0.41 
Diluted$0.33 $0.40 
Shares used to compute non-GAAP net income per share:
Basic24,135,32025,624,949
Diluted24,435,84425,784,987
1Stock-based compensation expense, amortization expense, unrealized (gain) loss on foreign currency and benefits related to exit and disposal activities were included in the following GAAP consolidated statement of operations categories:
Three Months Ended
March 31,
20252024
Cost of revenue$802 $801 
Marketing and sales778 833 
Research and development625 692 
General and administrative2,695 2,937 
Benefit related to exit and disposal activities(39)— 
Total operating expenses4,059 4,462 
Other income (loss), net(135)237 
Total adjustments$4,726 $5,500 
2For the three months ended March 31, 2025 and 2024, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Gross Margin
(In thousands)
(Unaudited)
Three Months Ended
March 31,
20252024
Revenue$126,205 $127,890 
Gross profit55,698 57,467 
GAAP gross margin44.1 %44.9 %
Add back:  
Stock-based compensation expense460 459 
Amortization expense342 342 
Total adjustments802 801 
Non-GAAP gross profit$56,500 $58,268 
Non-GAAP gross margin44.8 %45.6 %


Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)
Three Months Ended
March 31,
20252024
Revenue$126,205 $127,890 
Income from operations4,531 6,827 
GAAP operating margin3.6 %5.3 %
Add back:
Stock-based compensation expense3,992 4,276 
Amortization expense908 987 
Benefit related to exit and disposal activities(39)— 
Total adjustments4,861 5,263 
Non-GAAP income from operations$9,392 $12,090 
Non-GAAP operating margin7.4 %9.5 %


Proto Labs, Inc.
Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA
(In thousands)
(Unaudited)
Three Months Ended
March 31,
20252024
Revenue$126,205 $127,890 
GAAP net income3,599 5,268 
GAAP net income margin2.9 %4.1 %
Add back:
Amortization expense$908 $987 
Depreciation expense7,786 8,116 
Interest income, net(1,108)(1,112)
Provision for income taxes2,386 2,458 
EBITDA13,571 15,717 
EBITDA Margin10.8 %12.3 %
Add back:
Stock-based compensation expense3,992 4,276 
Unrealized (gain) loss on foreign currency(135)237 
Benefit related to exit and disposal activities(39)— 
Total adjustments3,818 4,513 
Adjusted EBITDA$17,389 $20,230 
Adjusted EBITDA Margin13.8 %15.8 %


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Region
(In thousands)
(Unaudited)
Three Months Ended
March 31, 2025		Three Months Ended
March 31, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAPGAAP
Revenues
United States$100,267 $— $100,267 $101,481 (1.2 %)(1.2 %)
Europe25,938 463 26,401 26,409 (1.8)— 
Total revenue$126,205 $463 $126,668 $127,890 (1.3 %)(1.0 %)

1Revenue for the three months ended March 31, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three months ended March 31, 2024 to GAAP revenue for the three months ended March 31, 2025.
3This column presents the percentage change from GAAP revenue for the three months ended March 31, 2024 to non-GAAP revenue for the three months ended March 31, 2025 (as recalculated using the foreign currency exchange rates in effect during the three months ended March 31, 2024) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth by Service Line
(In thousands)
(Unaudited)
Three Months Ended
March 31, 2025		Three Months Ended
March 31, 2024
%
Change2
% Change
Organic3
GAAP
Foreign
Currency1
Non-GAAPGAAP
Revenues
Injection Molding$48,723 $81 $48,804 $52,663 (7.5 %)(7.3 %)
CNC Machining52,843 305 53,148 49,932 5.8 6.4 
3D Printing20,194 64 20,258 21,582 (6.4)(6.1)
Sheet Metal4,211 10 4,221 3,553 18.5 18.8 
Other Revenue234 3 237 160 46.3 48.1 
Total revenue$126,205 $463 $126,668 $127,890 (1.3 %)(1.0 %)

1Revenue for the three months ended March 31, 2025 has been recalculated using 2024 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
2This column presents the percentage change from GAAP revenue for the three months ended March 31, 2024 to GAAP revenue for the three months ended March 31, 2025.
3This column presents the percentage change from GAAP revenue for the three months ended March 31, 2024 to non-GAAP revenue for the three months ended March 31, 2025 (as recalculated using the foreign currency exchange rates in effect during the three months ended March 31, 2024) in order to provide a constant-currency comparison.


Proto Labs, Inc.
Customer Contact Information
(In thousands, except customer contacts and per customer contact amounts)
(Unaudited)
Three Months Ended
March 31,
20252024
Revenue$126,205 $127,890 
Customer contacts21,62722,466
Revenue per customer contact1
$5,836 $5,693 

1Revenue per customer contact is calculated using the revenue recognized during the respective period divided by the actual number of customer contacts served during the same period. Customer contacts are product developers, engineers, procurement and supply chain professionals and other individuals who place an order, and that order is shipped and invoiced during the period. The Company believes revenue per customer contact is useful to investors in evaluating the underlying business trends and ongoing operating performance of the Company.
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Guidance
(Unaudited)

Q2 2025 Outlook
LowHigh
GAAP diluted net income per share$0.11 $0.19 
Add back:
Stock-based compensation expense0.16 0.16 
Amortization expense0.03 0.03 
Unrealized (gain) loss on foreign currency0.00 0.00 
Total adjustments0.19 0.19 
Non-GAAP diluted net income per share$0.30 $0.38